Risk Assessment of Death of Tumor-Related PTE by CAR Combined with DD Detection

• Published in: Vascular health and risk management Vol. 18; pp. 445 - 451
• Main Authors: Li, Xinran, Zheng, Jiamin, Lu, Ye, Pan, Xiangtao
• Format: Journal Article
• Language: English
• Published: Macclesfield Dove Medical Press Limited 01.01.2022; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Age; albumin; Amniotic fluid; Blood clots; Brain cancer; C-reactive protein; c-reactive protein/albumin ratio; Comparative analysis; Correlation analysis; Disease prevention; Gender; Hospitals; Lymphocytes; Medical prognosis; Medical records; Medical research; Medicine, Experimental; Mortality; neutrophil/lymphocyte; Neutrophils; Original Research; plasma d-dimer; Prognosis; Pulmonary arteries; Pulmonary embolisms; pulmonary thromboembolism; Risk assessment; risk assessment of death; Statistical analysis; Thromboembolism; Thrombosis; Tumors; Taiwan
• ISSN: 1178-2048; 1176-6344; 1178-2048
• DOI: 10.2147/VHRM.S365323

Objective: To investigate the risk of death in patients with tumor-related PTE (pulmonary thromboembolism) detected by CAR (C-reactive protein/albumin ratio) combined with DD (D-dimer). Methods: The peripheral hematology and coagulation-related indexes of 109 patients with tumor-related PTE diagnosed by PTCA were retrospectively analyzed, and the differences in relationship indexes between tumor-related PTE patients with good prognosis and poor prognosis were compared and analyzed. The receiver operating characteristic curve (ROC) was used to analyze the risk of death in patients with tumor-related PTE by CAR and DD. Results: [R] The values of CAR and DD in the poor prognosis group were 3.90 [+ or -] 2.69 and 21.25 [+ or -] 21.20, respectively, which were significantly higher than those in the good prognosis group (1.66 [+ or -] 1.77, 9.53 [+ or -] 3.57) (P all <0.01). 2 WBC, NE and SII in tumor-related PTE patients with poor prognosis were significantly higher than those in patients with good prognosis, while Hb in patients with poor prognosis was significantly lower than that in patients with good prognosis. 3 There was a significant positive correlation between CAR and DD (P=0.018). 4 The values of CAR and DD in the death group were 4.07 [+ or -] 2.42 and 19.65 [+ or -] 20.48, respectively, which were significantly higher than those in the survival group (1.94 [+ or -] 2.12, 11.52 [+ or -] 15.84) (P all<0.05). 5 The results of logistic regression analysis showed that both CAR (P=0.000) and DD (P=0.031) were independent prognostic factors in patients with tumor-related PTE. 6 CAR combined with DD had high sensitivity (77.8%) and specificity (83.5%), and the Youden index was 0.613. 7 The area under the receiver operating characteristic curve of CAR combined with DD was the largest (up to 0.806). Conclusion: CAR and DD were highly expressed in patients with poor prognosis of tumor-related PTE. CAR combined with DD detection is helpful to improve the correct assessment of the risk of death in patients with tumor-related PTE. Keywords: pulmonary thromboembolism, neutrophil/lymphocyte, C-reactive protein, albumin, C-reactive protein/albumin ratio, plasma D-dimer, risk assessment of death